Skip to main content
MNKD logo

MannKind Corporation

MNKDNASDAQHealthcareBiotechnology

$3.04Today:- (-)1Y −41.68%

As of Oct 16, 2026 close

Market cap
$986.32M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.23$6.51
Volume (live)
-
Avg. volume (3M)
4.98M

MannKind (MNKD) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), MannKind generated $18.25M of operating cash flow and spent $4.57M on capital expenditures. That left free cash flow of $13.69M, down 58.3% from $32.82M a year earlier, or 3.9% of revenue.

MannKind Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MannKind Corporation (MNKD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income5.8627.59-11.94-87.40-80.93-57.24-51.90-86.98-117.33
Depreciation & Amortization12.289.044.546.293.243.332.151.703.53
Deferred Income Tax-4.970.000.000.0012.6410.66-4.570.0012.94
Stock Based Compensation24.2021.3617.650.0012.206.516.206.864.85
Change in Working Capital-86.35-36.4716.73-24.05-17.73-9.78-12.3636.6827.58
Change in Accounts Receivable-4.762.652.35-11.81-0.78-0.710.50-1.34-2.49
Change in Inventory10.40-3.20-11.35-5.67-4.08-1.31-0.56-3.15-3.30
Change in Accounts Payable-16.71-2.79-1.474.101.370.79-0.59-1.613.80
Change in Other Working Capital-75.27-33.141.38-10.67-8.49-8.55-11.7142.7829.56
Other Operating Activities67.2321.001.3824.4721.5018.40-28.005.713.67
Net Cash from Operating Activities18.2642.5134.09-80.70-61.71-28.13-88.48-37.73-64.78
Investing Activities
Capital Expenditures-4.57-9.69-42.44-7.59-11.47-4.78-2.57-0.350.00
Acquisitions-347.740.000.00-15.34-56.06-3.980.000.120.02
Purchases of Investments-157.80-273.79-79.10-5.00-199.13-16.02-44.970.000.00
Sales/Maturities of Investments221.7258.13119.550.0059.0620.0024.990.000.00
Other Investing Activities-16.41128.710.3832.8056.0620.00-0.300.1216.68
Net Cash from Investing Activities-304.80-96.65-1.994.87-151.5415.22-22.84-0.2316.68
Financing Activities
Debt Repayment0.00-133.17-6.67-1.09-45.0514.8763.70-5.0015.43
Common Stock Issued-3.26-6.096.8922.561.9923.673.2070.5261.56
Common Stock Repurchased0.000.00-10.160.00-0.500.000.000.000.00
Other Financing Activities318.361.99134.57-0.06-16.4311.322.97-4.23-3.43
Net Cash from Financing Activities315.10-137.27136.6121.41270.2749.8569.8661.2973.56
Summary
Net Change in Cash28.55-191.40168.71-54.4257.0236.94-41.4623.3325.46
Cash at Beginning of Period47.08238.4869.77124.1867.1630.2271.6848.3622.90
Cash at End of Period75.6347.08238.4869.77124.1867.1630.2271.6848.36
Free Cash Flow13.6932.82-8.35-88.29-73.18-32.91-91.05-38.09-64.78
Supplemental Disclosures
Interest Paid-17.5118.288.8511.273.56---
Income Taxes Paid-4.26-------

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About MannKind Cash Flow

What is MannKind's free cash flow?

MannKind generated free cash flow of $13.69M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $18.25M minus $4.57M of capital expenditures. That was down 58.3% from $32.82M a year earlier. Free cash flow equaled 3.9% of revenue.

How much does MannKind spend on capital expenditures?

MannKind spent $4.57M on capital expenditures in fiscal 2025, compared with $9.69M a year earlier. That equals 25.0% of operating cash flow.

Does MannKind pay dividends or buy back shares?

MannKind's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition